Study title:
AN 02596504 Medline 20070101.
TI Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine.
SO American journal of medical genetics, {Am-J-Med-Genet}, Aug 1989,
vol. 33, no. 4, p. 457-67, ISSN: 0148-7299. AU Zatz-M, Rapaport-D, Pavanello-R-C, Rocha-J-M, Vainzof-M, Nicolau-W.
IN Departamento de Biologia, Universidade de Sao Paulo, Brazil. YR 1989.AN 02596504 Medline 20070101.
TI Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine.
SO American journal of medical genetics, {Am-J-Med-Genet}, Aug 1989,
vol. 33, no. 4, p. 457-67, ISSN: 0148-7299. AU Zatz-M, Rapaport-D, Pavanello-R-C, Rocha-J-M, Vainzof-M, Nicolau-W.
IN Departamento de Biologia, Univer...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Pathological Conditions, Signs and Symptoms [C23]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: CYPROHEPTADINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|